Genocea Biosciences (GNCAQ) Stock Statistics & Valuation Metrics

Genocea Biosciences has a market cap or net worth of $118.00. The enterprise value is ―.

Genocea Biosciences has 58,783,504 shares outstanding. The number of shares has decreased by -2.65% in one year.

Genocea Biosciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Genocea Biosciences is ―. Genocea Biosciences’s PEG ratio is ―.

In the last 12 months, Genocea Biosciences had revenue of ― and earned -33.20M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Genocea Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Genocea Biosciences upcoming earnings date is Feb 16, 2023, TBA (Confirmed).

Genocea Biosciences as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Genocea Biosciences has paid ― in taxes.

Genocea Biosciences EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Genocea Biosciences has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Genocea Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―